Literature DB >> 7699386

Persistent neuroleptic-induced rigidity and dystonia in AIDS dementia complex: a clinico-pathological case report.

S A Factor1, G D Podskalny, K D Barron.   

Abstract

Patients with AIDS dementia complex (ADC) appear to have an increased likelihood of developing acute onset parkinsonism and dystonia when treated with dopamine antagonists. It has been hypothesized, based on clinical evidence, that hypersensitivity to these drugs in ADC is probably related to direct invasion of the basal ganglia by the HIV virus and a secondary alteration in dopaminergic mechanisms. We report the first pathological description of a patient with ADC who developed acute onset, generalized rigidity and dystonia after a brief trial of low dose neuroleptic therapy administered for psychotic symptoms. An unusual clinical feature of this case was the persistence of his movement disorder. Pathological examination revealed a generalized encephalitic process with substantial neuronal loss observed primarily in the medial and lateral globus pallidus. Correlation with a current model of basal ganglia pathophysiology and other disorders with pallidal lesions is discussed. Clinical and pathological features of this case confirm the previous contention and indicate that dopamine antagonists should be utilized with extreme caution in patients with ADC.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7699386     DOI: 10.1016/0022-510x(94)90144-9

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  9 in total

1.  HIV-induced chorea: evidence for basal ganglia dysregulation by SPECT.

Authors:  B Sporer; R Linke; K Seelos; R Paul; T Klopstock; H-W Pfister
Journal:  J Neurol       Date:  2005-02-23       Impact factor: 4.849

Review 2.  PET brain imaging in HIV-associated neurocognitive disorders (HAND) in the era of combination antiretroviral therapy.

Authors:  Jaime H Vera; Basil Ridha; Yvonne Gilleece; Aliza Amlani; Patrick Thorburn; Sabina Dizdarevic
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-01-05       Impact factor: 9.236

Review 3.  Movement disorder emergencies.

Authors:  Steven J Frucht
Journal:  Curr Neurol Neurosci Rep       Date:  2005-07       Impact factor: 5.081

4.  Hyperdopaminergic tone in HIV-1 protein treated rats and cocaine sensitization.

Authors:  Mark J Ferris; Danielle Frederick-Duus; Jim Fadel; Charles F Mactutus; Rosemarie M Booze
Journal:  J Neurochem       Date:  2010-10-05       Impact factor: 5.372

Review 5.  Movement disorder emergencies.

Authors:  Kathleen L Poston; Steven J Frucht
Journal:  J Neurol       Date:  2008-08       Impact factor: 4.849

Review 6.  [Treatment of nausea and vomiting with prokinetics and neuroleptics in palliative care patients : a review].

Authors:  G Benze; B Alt-Epping; A Geyer; F Nauck
Journal:  Schmerz       Date:  2012-09       Impact factor: 1.107

7.  Decreased brain dopamine transporters are related to cognitive deficits in HIV patients with or without cocaine abuse.

Authors:  Linda Chang; Gene-Jack Wang; Nora D Volkow; Thomas Ernst; Frank Telang; Jean Logan; Joanna S Fowler
Journal:  Neuroimage       Date:  2008-05-20       Impact factor: 6.556

Review 8.  Neurotoxic profiles of HIV, psychostimulant drugs of abuse, and their concerted effect on the brain: current status of dopamine system vulnerability in NeuroAIDS.

Authors:  Mark J Ferris; Charles F Mactutus; Rosemarie M Booze
Journal:  Neurosci Biobehav Rev       Date:  2008-03-18       Impact factor: 8.989

9.  The human immunodeficiency virus-1-associated protein, Tat1-86, impairs dopamine transporters and interacts with cocaine to reduce nerve terminal function: a no-net-flux microdialysis study.

Authors:  M J Ferris; D Frederick-Duus; J Fadel; C F Mactutus; R M Booze
Journal:  Neuroscience       Date:  2009-01-20       Impact factor: 3.590

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.